MOTS-C // Mitochondrial Exercise Mimetic
A 16-amino acid mitochondrial-derived peptide that activates AMPK and improves metabolic homeostasis — mimicking some of the cellular benefits of exercise at the molecular level. MOTS-C represents a new class of retrograde mitochondrial signals that regulate nuclear gene expression. The bridge between metabolic health and longevity.
Your mitochondria talking to your nucleus.
MOTS-C is encoded in mitochondrial DNA but translocates to the nucleus during metabolic stress — a retrograde signal from mitochondria to the genome. It activates AMPK, the master metabolic regulator, improving glucose homeostasis, fat oxidation, and cellular stress resistance.
Consistent dosing, not burst protocol.
Unlike Khavinson bioregulators, MOTS-C uses a continuous dosing approach — 3–5 injections per week for sustained metabolic optimization. Think of it as a supplement for your mitochondria.
Pinchas Cohen's mitochondrial discovery.
MOTS-C was discovered by Pinchas Cohen's group at USC in 2015, published in Cell Metabolism. It was the first mitochondrial-derived peptide shown to regulate nuclear gene expression — establishing a new paradigm in mito-nuclear communication.
Key findings showed that MOTS-C levels decline with age and correlate with metabolic disease. Exogenous MOTS-C improved glucose homeostasis in aged and obese mice, enhanced exercise capacity, and activated AMPK-dependent metabolic pathways.
A groundbreaking 2020 study showed MOTS-C translocates to the nucleus during metabolic stress, where it directly regulates adaptive gene expression through interactions with the antioxidant response element (ARE). This established MOTS-C as both a hormone and a transcription regulator.
Mitochondrial peptide comparison.
| Compound | Origin | Target | Primary Effect | Protocol |
|---|---|---|---|---|
| MOTS-C | mtDNA (12S rRNA) | AMPK / Nucleus | Metabolic Optimization | 3–5x/week |
| SS-31 | Synthetic | Cardiolipin | ETC Efficiency | Daily |
| Humanin | mtDNA (16S rRNA) | Multi-receptor | Cytoprotection | Daily |
| NAD+/NMN | Precursor | Sirtuins | NAD+ Restoration | Daily oral |
What to watch for.
MOTS-C's side effect profile is manageable with proper protocol adherence. Baseline blood work before starting and periodic monitoring during use is essential.
- Injection site reactions (mild)
- Possible hypoglycemia (glucose-lowering effect — monitor)
- Mild GI effects (uncommon)
- Limited human safety data
- Monitor blood glucose closely if diabetic or on metformin
- Generally well tolerated in reported use
- Fasting glucose and fasting insulin
- HbA1c (3-month glucose average)
- HOMA-IR (insulin resistance index)
- Lipid panel (triglycerides respond to AMPK activation)
- Lactate (exercise capacity marker)
- Comprehensive metabolic panel
- IGF-1 (general metabolic/aging marker)
- Epithalon for telomere + mitochondrial longevity coverage (Anti-Aging Stack)
- SS-31 for comprehensive mitochondrial protection
- NAD+/NMN for complementary metabolic pathway support
- Exercise amplifies MOTS-C effects — train during protocol
- Monitor glucose if stacking with other glucose-lowering compounds
- Retatrutide users: MOTS-C adds non-GLP-1 metabolic support
- Lyophilized: refrigerate at 2–8°C (36–46°F)
- Reconstituted: refrigerate, use within 21 days
- Protect from light
- Do not freeze reconstituted solution
- 16-amino acid — moderate stability
Compounds that complement MOTS-C.
Exercise in a vial — but it doesn't replace the gym.
MOTS-C represents a genuinely new class of biological signaling — mitochondrial peptides that regulate nuclear gene expression. The exercise-mimetic framing is compelling but incomplete: MOTS-C activates AMPK and improves metabolic homeostasis, but it doesn't build muscle, improve cardiovascular fitness, or replace the neurological benefits of training. Think of it as a metabolic amplifier that makes exercise and caloric restriction more effective at the cellular level. Stack with Epithalon and SS-31 for the complete Anti-Aging Stack. Monitor glucose closely — the AMPK activation is real and can cause hypoglycemia.
Our free Protocol Guide includes the complete Anti-Aging Stack — MOTS-C, Epithalon, SS-31, and NAD+ with metabolic tracking templates.